Dan Brennan
Stock Analyst at TD Cowen
(4.16)
# 410
Out of 4,760 analysts
104
Total ratings
50%
Success rate
13.69%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reinstates: Buy | $74 | $45.17 | +63.83% | 2 | Feb 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $75 → $118 | $89.66 | +31.61% | 3 | Jan 7, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $44.97 | +91.24% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $132.63 | +31.95% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $175.12 | +42.76% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $47.40 | +47.68% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $85.97 | +105.89% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $118.23 | +21.80% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $390.29 | +5.05% | 3 | Nov 4, 2024 | |
| DHR Danaher | Maintains: Buy | $310 → $315 | $205.23 | +53.49% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $121.90 | +31.26% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $35.84 | +17.19% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8.5 → $11 | $2.86 | +284.62% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $9.60 | +212.50% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $17.28 | +79.40% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $526.80 | +24.91% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $46.49 | +9.70% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.81 | +247.27% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $9.09 | +120.14% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $10.59 | +202.17% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $333.77 | +63.59% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.42 | +392.96% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.39 | +979.14% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $182.72 | +26.97% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,294.40 | -32.01% | 3 | Oct 7, 2020 |
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $45.17
Upside: +63.83%
GeneDx Holdings
Jan 7, 2025
Maintains: Buy
Price Target: $75 → $118
Current: $89.66
Upside: +31.61%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $44.97
Upside: +91.24%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $132.63
Upside: +31.95%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $175.12
Upside: +42.76%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $47.40
Upside: +47.68%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $85.97
Upside: +105.89%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $118.23
Upside: +21.80%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $390.29
Upside: +5.05%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $205.23
Upside: +53.49%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $121.90
Upside: +31.26%
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $35.84
Upside: +17.19%
Aug 8, 2024
Maintains: Neutral
Price Target: $8.5 → $11
Current: $2.86
Upside: +284.62%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $9.60
Upside: +212.50%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $17.28
Upside: +79.40%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $526.80
Upside: +24.91%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $46.49
Upside: +9.70%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.81
Upside: +247.27%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $9.09
Upside: +120.14%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $10.59
Upside: +202.17%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $333.77
Upside: +63.59%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.42
Upside: +392.96%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.39
Upside: +979.14%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $182.72
Upside: +26.97%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,294.40
Upside: -32.01%